Multicentric evaluation of the homogeneous LDL-cholesterol Plus assay: Comparison with beta-quantification and Friedewald formula

Clinical Biochemistry

Volumn 41, Issue 16-17, 2008, Pages 1402-1409

  Esteban Salan, Margarita ^a   Aguilar Doreste, José Angel ^b   Arranz Pena, Maria Luisa ^c   Juve Cuxart, Santiago ^d   Gich Salarich, Ignasi ^e   Zapico Muniz, Edgar ^e   Ordonez Llanos, Jordi ^e,f,g  

^a HOSPITAL DE GALDAKAO   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^d Roche Diagnostics   (Spain)

^e HOSPITAL SANT PAU   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g MLS ^*

Author keywords

Direct method; LDL cholesterol; Method comparison

Indexed keywords

BILIRUBIN; CHYLOMICRON; HEMOGLOBIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ASSAY; BETA QUANTIFICATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DIRECT LOW DENSITY LIPOPROTEIN CHOLESTEROL PLUS ASSAY; FRIEDEWALD FORMULA; HUMAN; INTERMETHOD COMPARISON; MATHEMATICAL ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

BIAS (EPIDEMIOLOGY); BLOOD CHEMICAL ANALYSIS; CHOLESTEROL, LDL; HUMANS; LABORATORIES;

EID: 55249120662     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.07.014     Document Type: Article

References (30)

1. Grundy S.M. Role of low-density lipoproteins in atherogenesis and development of coronary heart disease. Clin Chem 41 (1995) 139-146
2. Gordon T., Kannel W.B., Castelli W.P., and Dawber T.R. Lipoproteins, cardiovascular disease and death. The Framingham Study. Arch Intern Med 141 (1981) 1128-1131
3. Assmann G., Cullen P., and Schulte H. The Münster Heart Study (PROCAM). Eur Heart J 19 (1998) A2-A11
4. Castelli W.P., Garrison R.J., Wilson P.W., Abbott R.D., Kalousdian S., and Kannel W.B. Incidence of coronary heart disease and lipoprotein levels. The Framingham Study. JAMA 256 (1986) 2835-2838
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
6. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., and Dallongeville J. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24 (2003) 1601-1610
7. Bachorik P.S., and Ross J.W. National Cholesterol Education Program Recommendations for measurement of low-density cholesterol: Executive summary. The National Cholesterol Education Program Working Group on lipoprotein measurement. Clin Chem 41 (1995) 1414-1420
8. Friedewald W.T., Levy R.J., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
9. McNamara J.R., Cohn J.S., Wilson P.W.F., and Schaefer E.J. Calculated values of low-density lipoprotein in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 36 (1990) 36-42
10. Rubiés-Prat J., Reverter J.L., Sentí M., et al. Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus. Diabetes Care 16 (1993) 1081-1086
11. Matas C., Cabre M., La Ville A., et al. Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease. Clin Chem 40 (1994) 404-406
12. Wägner A.M., Sánchez-Quesada J.L., Pérez A., et al. Inaccuracy of calculated LDL-cholesterol in type 2 diabetes: consequences for patient risk classification and therapeutic decisions. Clin Chem 46 (2000) 1830-1832
13. Nauck M., Warnick G.R., and Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 48 (2002) 236-254
14. Nauck M., Graziani M.S.B., Bruton D., et al. Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: a multicenter evaluation. Clin Chem 46 (2000) 506-514
15. Esteban-Salán M., Guimón-Bardesi A., De la Viuda-Unzueta J.M., Azcarate-Ania M.N., Pascual-Usandizaga P., and Amoroto-Del-Rio E. Analytical and clinical evaluation of two homogeneous assays for LDL-cholesterol in hyperlipidemic patients. Clin Chem 46 (2000) 1121-1131
16. Miller W.G., Waimack P.P., Anderson F.P., Etridge S.F., and Jaine E.C. Performance of four homogeneous direct methods for LDL-cholesterol. Clin Chem 48 (2002) 489-498
17. Bayer P., Veinberg F., Couderc R., et al. Évaluation multicentrique de quatre méthodes de dosage direct du cholestérol-LDL. Ann Biol Clin 63 (2005) 27-41
18. Glick M.R., Ryder K.W., and Jackson J.A. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 32 (1986) 470-475
19. Tremblay A.J., Morrissette H., Gagné J.M., Bergeron J., Gagné C., and Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 37 (2004) 785-790
20. Bairaktari E., Elisaf M., Tzallas C., et al. Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients. Clin Biochem 34 (2001) 593-602
21. Sniderman A.D., Blank D., Zakarian R., Bergeron J., and Frohlich J. Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula. Clin Biochem 36 (2003) 499-504
22. Usui S., Kakuuchi H., Okamoto M., Mizukami Y., and Okasaki M. Differential reactivity of two homogeneous LDL-cholesterol methods to LDL and VLDL subfractions, as demonstrated by ultracentrifugation and HPLC. Clin Chem 48 (2002) 1946-1954
23. Sakue T., Hirano T., Yoshino G., Sakai K., Takeuchi H., and Adachi M. Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: comparison of three homogeneous methods. Clin Chim Acta 295 (2000) 97-106
24. Fei H., Maeda S., Kirii H., Fujigaki S., Maekawa N., Fujii H., et al. Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum. Clin Chem 46 (2000) 1351-1356
25. Warnick G.R. Lack of agreement of homogeneous assays with the reference method for LDL-cholesterol may not indicate unreliable prediction of risk for cardiovascular disease. Clin Chem 48 (2002) 1812-1815
26. Ordonez-Llanos J., Wägner A.M., Bonet-Marqués R., Sánchez-Quesada J.L., Blanco-Vaca F., and González-Sastre F. Which cholesterol are we measuring with the Roche direct, homogeneous LDL-C Plus assay?. Clin Chem 47 (2001) 124-126
27. Iwasaki Y., Matsumaya H., and Nakashima N. Improved specificity of a new homogeneous assay for LDL-cholesterol in serum with abnormal lipoproteins. Clin Chem 52 (2006) 886-888
28. Gómez F., Camps J., Simó J.M., Ferré N., and Joven J. Agreement study for the measurement of LDL- and HDL-cholesterol compared with ultracentifugation in patients with liver cirrhosis. Clin Chem 46 (2000) 1188-1191
29. Kurosawa H., Yoshida H., Yanai H., Ogura Y., Hirowatari Y., and Tada N. Comparative study between anion-exchange HPLC and homogeneous assay methods in regard to the accuracy of high- and low-density lipoprotein cholesterol measurement. Clin Biochem 40 (2007) 1291-1296
30. Garcia-Helj C., Vest P., Renard C., Merens-Gonthier A., Boukhira A., and Thefenne-Astier H. Falsely Low LDL cholesterol results and cholestasis. Clin Chem 52 (2006) 2125-2127